11-Nov-2015 - Merck KGaA

Merck Set to Complete Sigma-Aldrich Acquisition

European Commission approves sale of divestment business to Honeywell

Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich.

The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the divestment of certain Sigma-Aldrich assets. On October 20, 2015, Merck announced an agreement to sell parts of Sigma-Aldrich’s solvents and inorganics business to Honeywell. Now that the European Commission has approved that transaction, all necessary closing requirements have been fulfilled for Merck to complete the acquisition of Sigma-Aldrich. The formal completion date is scheduled for November 18, with the delisting of Sigma-Aldrich’s stock from NASDAQ taking effect following completion.

“We’ve reached the home stretch and are set to complete the largest acquisition in our almost 350-year history,” said Karl-Ludwig Kley, CEO and Chairman of Merck.

Merck and Sigma-Aldrich announced on September 22, 2014 that they had entered into a definitive agreement under which Merck would acquire all outstanding shares of Sigma-Aldrich for $140 per share in cash. Today’s final approval of the European Commission follows the approval of the acquisition by Sigma-Aldrich’s shareholders at a special meeting held on December 5, 2014 and the satisfaction of other customary conditions, including antitrust clearance in the United States, China, Japan and several other countries.

Facts, background information, dossiers
  • Merck
  • Honeywell
  • acquisitions
  • Sigma-Aldrich
More about Merck
More about Sigma-Aldrich
  • News

    Merck Completes Sigma-Aldrich Acquisition

    Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more

    Merck announces Sigma-Aldrich business sale to Honeywell

    Merck announced that Sigma-Aldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisiti ... more

    Merck progresses toward completion of Sigma-Aldrich acquisition

    Merck announced that it had obtained all necessary antitrust approvals, with the approval of the European Commission being conditional upon the sale of parts of Sigma-Aldrich’s solvents and inorganics business. Negotiations with potential buyers are in the final stage. Once a binding agreem ... more

  • Companies

    Sigma-Aldrich Chemie GmbH

    more

    Sigma-Aldrich Corp.

    Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

    Sigma-Aldrich Química, S.A. de C.V.

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more